Tech EU News
Novartis and GSK swap assets in pharma industry reshape – economy
There has been a major shake-up in the drugmaking world. Swiss firm Novartis is selling its animal medicines division and swapping assets with Britain’s GlaxoSmithKline.
It means GSK will no longer make anti-cancer drugs and it will acquire Novartis’ vaccines division.
The aim is to bolster their best businesses and exit weaker ones as part of the reshaping of the drugs industry:
Mike Ingram, Market Analyst, BGC Partners said: “It’s positive news for shareholders, clearly what’s going on in…
READ MORE : http://www.euronews.com/2014/04/22/novartis-and-gsk-swap-assets-in-pharma-industry-reshape
What is in the news today? Click to watch: http://eurone.ws/1kb2gOl
euronews: the most watched news channel in Europe
Subscribe! http://eurone.ws/10ZCK4a
euronews is available in 14 languages: http://eurone.ws/17moBCU
In English:
Website: http://www.euronews.com/news
Facebook: http://www.facebook.com/euronews
Twitter: http://twitter.com/euronews
Google+: http://google.com/+euronews
VKontakte: http://vk.com/en.euronews
source
You must be logged in to post a comment Login